OESOPHAGEAL SQUAMOUS CELL CARCINOMA

This adverse event was reported 245 times

These drugs are most commonly taken by patients reporting OESOPHAGEAL SQUAMOUS CELL CARCINOMA:

# Drug Count
0 METHOTREXATE SODIUM 32
1 METHOTREXATE 29
2 PREDNISONE 24
3 TACROLIMUS 23
4 LENALIDOMIDE 22
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 21
6 TACROLIMUS OINTMENT 0.1% 21
7 CYCLOSPORINE 20
8 DEXAMETHASONE 19
9 DEXAMETHASONE 1.5 MG 19
See all common drugs associated with OESOPHAGEAL SQUAMOUS CELL CARCINOMA

OESOPHAGEAL SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE 1 0.0303
1 NITROGEN 1 0.0090
2 PORFIMER SODIUM 2 0.0059
3 BEROTRALSTAT HYDROCHLORIDE 1 0.0011
4 BELATACEPT 5 0.0011
5 OMEPRAZOLE 20MG 1 0.0009
6 ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE 5 0.0008
7 TAZEMETOSTAT 1 0.0006
8 ALOGLIPTIN 2 0.0006
9 MITOTANE 1 0.0005
See all drugs enriched for association with OESOPHAGEAL SQUAMOUS CELL CARCINOMA